Clinical research also revealed that biomarkers of inflammation, such as inflammatory cytokines and acute-phase proteins, are reliably increased in a proportion of patients with major depressive disorder (MDD), bipolar disorder, anxiety disorders, and posttraumatic stress disorder (PTSD) (Felger 2018). The gene discussed is DDAH2; the disease is bipolar disorder.